Pfizer (XBRU:PFEBC) Long-Term Debt : €55,478 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Pfizer Long-Term Debt?

Pfizer's Long-Term Debt for the quarter that ended in Dec. 2023 was €55,478 Mil.

Pfizer's quarterly Long-Term Debt increased from Jun. 2023 (€56,632 Mil) to Sep. 2023 (€57,202 Mil) but then declined from Sep. 2023 (€57,202 Mil) to Dec. 2023 (€55,478 Mil).

Pfizer's annual Long-Term Debt declined from Dec. 2021 (€30,760 Mil) to Dec. 2022 (€30,137 Mil) but then increased from Dec. 2022 (€30,137 Mil) to Dec. 2023 (€55,478 Mil).

Pfizer Long-Term Debt Historical Data

The historical data trend for Pfizer's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Long-Term Debt Chart

Pfizer Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

31,185.00

29,239.36

30,759.95

30,137.20

55,477.58

Pfizer Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															28,709.29	56,631.59	57,201.98	55,477.58	-

Pfizer (XBRU:PFEBC) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Pfizer Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Pfizer's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Pfizer (XBRU:PFEBC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (XBRU:PFEBC) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

PFE:USA PFE:Peru PFE:Mexico PFE_KZ:Kazakhstan 1PFE:Italy PFEd:UK 0Q1N:UK PFE:Germany PFE:Chile PFE:Canada PFIZ34:Brazil PFE:Austria PFE:Argentina

Address

66 Hudson Boulevard East, New York, NY, USA, 10001-2192

Website

https://www.pfizer.com

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

Pfizer (XBRU:PFEBC) Headlines

No Headlines